p57kip2在肝癌组织中的表达及其与临床病理因素、PCNA和p53的关系
原发性肝癌,,p57kip2基因;原发性肝癌;增殖细胞核抗原;p53,0引言,1材料和方法,2结果,3讨论,【参考文献
Expression of p57kip2 and its relationships with clinicopathology, PCNA and p53 in primary hepatocellular carcinomaGUO Hui, NAN KeJun, RUAN ZhiPing, JING Zhao, LIU ShaanXi
1Department of Oncology, 2Department of Hematology, First Hospital, Xi’an Jiaotong University, Xi’an 710061, China
【Abstract】 AIM: To investigate the expression of p57kip2 and its relationship with clinicopathology, PCNA and p53 in primary hepatocellular carcinoma (HCC). METHODS: Expression of p57kip2, PCNA and p53 in tumor tissues from 32 patients with HCC and 10 liver tissues of normal persons was detected with Elivision immunohistochemical technique. RESULTS: p57kip2 protein positiveexpression rate in HCC was 56.2%,which was lower than that in normal tissues (100%) (P=0.011). The reduced expression of p57kip2 protein correlated significantly with moderate or lowdifferentiation of tumor cells (P=0.007), high clinical stage (P=0.041) and poor prognosis (P=0.036), but did not correlate significantly with metastasis, tumor size, level of AFP and age (P>0.05). PCNA positiveexpression rate was 56.2%, which was correlated significantly with the expression of p57kip2 (P=0.036) and p53 positiveexpression rate was 46.9%, which was not correlated significantly with the expression of p57kip2 (P>0.05). CONCLUSION: There is a marked loss or absence of p57kip2 expression and high expression of PCNA in HCC, which are involved in the carcinogenesis and development of HCC. p57kip2 and p53 may induce apoptosis via different mechanisms. ......
您现在查看是摘要页,全文长 12418 字符。